• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT WITH NICORE¿ GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT WITH NICORE¿ GUIDEWIRE Back to Search Results
Catalog Number 786426
Medical Device Problem Code Partial Blockage (1065)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/12/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.H11: section a through f - the information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event or Problem Description
It was reported that when in use during operation, the stent was found occluded so that the urine could not be drained.As per the follow up information received via ibc on 20sep2023, the ureteral stent was used for laparoscopic right ureteral bladder replantation and was replaced with a new stent when the stent was found to be blocked during intraoperative use and urine could not be drained.
 
Additional Manufacturer Narrative
The reported event is unconfirmed as the product meets specifications.Visual evaluation noted visual requirements state to use unaided eye at 12" to 18" distance under normal room lighting unless otherwise noted.No defects were evaluated while performing the visual inspection.The suture and pigtail straightener were not provided for evaluation.Dimensional evaluation noted dimensional requirements state the od is to be 0.061" ± 0.002" and the guidewire to be 0.035" ± 0.001".The sample passed od measuring at 0.0627" using a laser micrometer.When inserting the guidewire there was no hesitation.No root cause could be found because the reported event was unconfirmed.A dhr reviews are not required for this complaint.The labelling review is not required as the reported event is unconfirmed.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : the actual/suspected device was inspected.
 
Event or Problem Description
It was reported that when in use during operation, the stent was found occluded so that the urine could not be drained.As per the follow up information received via ibc on 20sep2023, the ureteral stent was used for laparoscopic right ureteral bladder replantation and was replaced with a new stent when the stent was found to be blocked during intraoperative use and urine could not be drained.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY OPTIMA® URETERAL STENT WITH NICORE¿ GUIDEWIRE
Common Device Name
URETERAL STENT
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer Contact
xeeroy rada
8195 industrial blvd
covington 30014
7707846100
MDR Report Key17903904
Report Number1018233-2023-07281
Device Sequence Number15339303
Product Code FAD
UDI-Device Identifier10801741015042
UDI-Public(01)10801741015042
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K043193
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/24/2024
Device Catalogue Number786426
Device Lot NumberNGGW1576
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/17/2023
Supplement Date Received by Manufacturer11/23/2023
Initial Report FDA Received Date10/10/2023
Supplement Report FDA Received Date11/27/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/28/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-